Bupropion vs Venlafaxine

Both bupropion and venlafaxine are effective for major depressive disorder. The 2018 Cipriani et al. Lancet network meta-analysis found venlafaxine among the most effective antidepressants, with bupropion also demonstrating good efficacy.

Venlafaxine has broader FDA indications: MDD, generalized anxiety disorder (GAD), social anxiety disorder, and panic disorder. Its dual mechanism (serotonin + norepinephrine) makes it particularly effective for anxiety-predominant depression and mixed anxiety-depression.

Bupropion is FDA-approved for MDD, seasonal affective disorder (SAD), and smoking cessation (as Zyban). It is often used off-label for ADHD and as an augmentation strategy combined with SSRIs. Bupropion is not effective for anxiety disorders and may worsen anxiety in some patients.

For treatment-resistant depression, combining bupropion with an SSRI is one of the most common augmentation strategies, supported by the STAR*D trial results.

The side effect profiles of these two drugs are strikingly different due to their distinct mechanisms:

Sexual dysfunction: Bupropion has the lowest rate of sexual side effects among antidepressants, comparable to placebo. Venlafaxine, like SSRIs, commonly causes sexual dysfunction (decreased libido, anorgasmia, erectile dysfunction).

Weight: Bupropion is weight-neutral to mildly weight-reducing and is one of the few antidepressants not associated with weight gain. Venlafaxine may cause modest weight gain, particularly at higher doses and with longer use.

Anxiety/Activation: Bupropion can cause activation, insomnia, and anxiety, particularly early in treatment. It is generally not recommended for patients with anxiety disorders. Venlafaxine treats anxiety but can also cause initial anxiety and insomnia during dose titration.

Discontinuation: Venlafaxine has among the highest rates of discontinuation syndrome of all antidepressants — comparable to or worse than paroxetine. Careful tapering is essential. Bupropion has a much milder discontinuation profile.

Seizure risk: Bupropion lowers the seizure threshold and is contraindicated in patients with seizure disorders, eating disorders (anorexia/bulimia), or those undergoing abrupt alcohol/benzodiazepine withdrawal. The risk is dose-dependent.

Blood pressure: Venlafaxine can cause dose-dependent hypertension, requiring blood pressure monitoring. Bupropion can also raise blood pressure but less consistently.

Both are available as inexpensive generics. Bupropion has been generic in various formulations since the early 2000s, and venlafaxine since 2006 (extended-release since 2010). A 30-day supply of either typically costs $4-$25.

Bupropion extended-release (XL) and venlafaxine extended-release (ER) are the most commonly prescribed formulations and both are available as affordable generics.

Bupropion is available in immediate-release (3 times daily), sustained-release (twice daily), and extended-release (once daily) formulations. Venlafaxine is available as immediate-release (2-3 times daily) and extended-release (once daily).

Both drugs are most conveniently taken as their once-daily extended-release formulations. Bupropion XL is typically taken in the morning due to its activating properties. Venlafaxine ER can be taken morning or evening with food.

Venlafaxine requires careful, slow tapering when discontinuing (typically over weeks to months). Bupropion can be stopped more easily.

Bupropion is an excellent choice for patients concerned about sexual side effects, weight gain, or those with seasonal affective disorder, smoking cessation needs, or ADHD symptoms. It is also a top choice for augmenting an SSRI.

Venlafaxine is preferred when anxiety is a prominent component of the depression, for specific anxiety disorders (GAD, social anxiety, panic), or when a more broadly effective antidepressant is needed. It is often used when SSRIs have been ineffective.

Bupropion should be avoided in patients with seizure disorders, eating disorders, or significant anxiety. Venlafaxine should be used cautiously in patients with uncontrolled hypertension. Discuss your specific symptoms and concerns with your healthcare provider.